Geode Capital Management »

Enliven Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 682k 23.37
2024-03-31 $8.4M 476k 17.59
2023-09-30 $5.9M 433k 13.66
2023-06-30 $8.5M 414k 20.41
2023-03-31 $775k 35k 21.90